| Persistent and relapsing babesiosis in immunocompromised patients PJ Krause, BE Gewurz, D Hill, FM Marty, E Vannier, IM Foppa, ... Clinical Infectious Diseases 46 (3), 370-376, 2008 | 352 | 2008 |
| Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries Y Hsia, BR Lee, A Versporten, Y Yang, J Bielicki, C Jackson, J Newland, ... The Lancet Global Health 7 (7), e861-e871, 2019 | 266 | 2019 |
| Optimizing bactericidal exposure for β‐lactams using prolonged and continuous infusions in the pediatric population JD Courter, JL Kuti, JE Girotto, DP Nicolau Pediatric blood & cancer 53 (3), 379-385, 2009 | 87 | 2009 |
| Multidisciplinary guidance regarding the use of immunomodulatory therapies for acute coronavirus disease 2019 in pediatric patients DE Dulek, RC Fuhlbrigge, AC Tribble, JA Connelly, MM Loi, H El Chebib, ... Journal of the Pediatric Infectious Diseases Society 9 (6), 716-737, 2020 | 70 | 2020 |
| Appropriateness of antibiotic prescribing in United States children’s hospitals: a national point prevalence survey AC Tribble, BR Lee, KB Flett, LK Handy, JS Gerber, AL Hersh, ... Clinical Infectious Diseases 71 (8), e226-e234, 2020 | 59 | 2020 |
| Increased clinical failures when treating acute otitis media with macrolides: a meta-analysis JD Courter, WL Baker, KS Nowak, LA Smogowicz, LL Desjardins, ... Annals of Pharmacotherapy 44 (3), 471-478, 2010 | 57 | 2010 |
| Recombinant human growth hormone in the treatment of patients with cystic fibrosis OJ Phung, CI Coleman, EL Baker, JM Scholle, JE Girotto, SS Makanji, ... Pediatrics 126 (5), e1211-e1226, 2010 | 48 | 2010 |
| Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS): a quality improvement collaborative JG Newland, JS Gerber, MP Kronman, G Meredith, BR Lee, C Thurm, ... Journal of the Pediatric Infectious Diseases Society 7 (2), 124-128, 2018 | 45 | 2018 |
| Making a case for pediatric antimicrobial stewardship programs HK Magsarili, JE Girotto, NJ Bennett, DP Nicolau Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (11 …, 2015 | 40 | 2015 |
| Use of Monte Carlo simulation to assess the pharmacodynamics of β-lactams against pseudomonas aeruginosa infections in children: A report from the OPTAMA program DPN Jennifer M Ellis, Joseph L Kuti Clinical Therapeutics 27 (11), 1820-1830, 2005 | 39 | 2005 |
| Pharmacodynamic target attainment of oral β-lactams for the empiric treatment of acute otitis media in children RM Fallon, JL Kuti, GV Doern, JE Girotto, DP Nicolau Pediatric Drugs 10, 329-335, 2008 | 37 | 2008 |
| Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent RMS Germain, S Yigit, L Wells, JE Girotto, JC Salazar AIDS Patient Care and STDs 21 (6), 373-377, 2007 | 33 | 2007 |
| Management of pediatric acute hematogenous osteomyelitis, Part I: antimicrobial stewardship approach and review of therapies for methicillin‐susceptible Staphylococcus aureus … KJ DeRonde, JE Girotto, DP Nicolau Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (9 …, 2018 | 32 | 2018 |
| Pediatric antimicrobial stewardship programs K Nichols, S Stoffella, R Meyers, J Girotto, ... The Journal of Pediatric Pharmacology and Therapeutics 22 (1), 77-80, 2017 | 29 | 2017 |
| In vitro Activity of Ceftolozane/Tazobactam Alone or with an Aminoglycoside Against Multi-Drug-Resistant Pseudomonas aeruginosa from Pediatric Cystic Fibrosis … AM Dassner, C Sutherland, J Girotto, DP Nicolau Infectious diseases and therapy 6, 129-136, 2017 | 24 | 2017 |
| Management of Pediatric Acute Hematogenous Osteomyelitis, Part II: A Focus on Methicillin‐Resistant Staphylococcus aureus, Current and Emerging Therapies KJ DeRonde, JE Girotto, DP Nicolau Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (10 …, 2018 | 18 | 2018 |
| Ceftazidime/avibactam and ceftolozane/tazobactam: novel therapy for multidrug resistant gram negative infections in children BA Rodriguez, JE Girotto, DP Nicolau Current Pediatric Reviews 14 (2), 97-109, 2018 | 18 | 2018 |
| Management of pneumonia in the pediatric critical care unit: an area for antimicrobial stewardship A M Dassner, D P Nicolau, J E Girotto Current pediatric reviews 13 (1), 49-66, 2017 | 18 | 2017 |
| Pharmacodynamic Evaluation of Meropenem (MER) and Cefotaxime (CTX) for Pediatric Meningitis – A Report from the OPTAMA Program DPN Jennifer M Ellis, Joseph L Kuti Pediatric Drugs 8, 131-138, 2006 | 18* | 2006 |
| One size fits all? Application of susceptible-dose-dependent breakpoints to pediatric patients and laboratory reporting LE Nielsen, JB Forrester, JE Girotto, AM Dassner, R Humphries Journal of Clinical Microbiology 58 (1), 10.1128/jcm. 01446-19, 2019 | 14 | 2019 |
